Harbour Investments’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8 Hold
8
﹤0.01% 4646
2025
Q4
$15 Hold
8
﹤0.01% 3831
2025
Q3
$20 Hold
8
﹤0.01% 3714
2025
Q2
$37 Hold
8
﹤0.01% 3562
2025
Q1
$52 Hold
8
﹤0.01% 3498
2024
Q4
$69 Hold
8
﹤0.01% 3429
2024
Q3
$60 Buy
+8
New +$257 ﹤0.01% 3342
2024
Q2
Sell
-8
Closed -$739 3377
2024
Q1
$739 Hold
8
﹤0.01% 2985
2023
Q4
$615 Hold
8
﹤0.01% 2895
2023
Q3
$675 Buy
+8
New +$929 ﹤0.01% 2764
2023
Q2
Hold
0
3006
2023
Q1
Hold
0
2966
2022
Q4
Hold
0
2913
2022
Q3
Hold
0
2841
2022
Q2
Hold
0
2841
2021
Q4
Hold
0
2440

Other funds holding VTAK

Harbour Investments's VTAK Position: Q1 2026 in Review

Harbour Investments held its Catheter Precision (VTAK) position steady in Q1 2026 at 8 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #4646.

Harbour Investments first reported a position in VTAK in Q3 2023 and has held it in 10 quarters since. The position peaked at $739 in Q1 2024. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Harbour Investments held 8 shares of Catheter Precision worth $8 as of Q1 2026.
  • Harbour Investments left its Catheter Precision share count unchanged in Q1 2026.
  • Catheter Precision made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4646 holding.
  • Harbour Investments first reported a position in Catheter Precision in Q3 2023 and has held it in 10 quarters since.
  • Harbour Investments's Catheter Precision position peaked at $739 in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.